Mer­ck KGaA adds to gene ther­a­py man­u­fac­tur­ing boom with €100M fa­cil­i­ty in Cal­i­for­nia

Add a new, €100 mil­lion Cal­i­for­nia fa­cil­i­ty to the grow­ing gene ther­a­py in­fra­struc­ture.

Mer­ck KGaA an­nounced they are open­ing a sec­ond gene ther­a­py and vi­ral vec­tor fac­to­ry in Carls­bad, Cal­i­for­nia. The new cen­ter will be just one point in the glob­al sup­ply chain Big Phar­ma is rapid­ly erect­ing to keep man­u­fac­tur­ing ca­pac­i­ty for the new tech­nol­o­gy at pace with clin­i­cal de­vel­op­ment. Over the past year, No­var­tis, PTC Ther­a­peu­tics, Pfiz­er and Ver­tex each an­nounced or opened new fa­cil­i­ties in Switzer­land, North Car­oli­na and New Jer­sey that will help build gene ther­a­py.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER